In a patient restarting clozapine at 25 mg nightly after normal laboratory results, how should the dose be increased and what is the appropriate timing for titration?

Clozapine Dose Titration After Restart

Increase clozapine by 25-50 mg per day if well-tolerated, aiming to reach 300-450 mg daily (in divided doses) by the end of 2 weeks. 1

Initial Titration Schedule

Since you've already started at 25 mg nightly, the FDA-approved titration schedule recommends:

• Current dose: 25 mg once daily
• Days 2-7: Increase to 25 mg twice daily (50 mg total) if tolerated
• Week 2 onwards: Increase by 25-50 mg increments daily if well-tolerated
• Target by end of week 2: 300-450 mg daily in divided doses 1

Critical Safety Considerations During Titration

Orthostatic hypotension and cardiac risks are highest during initial titration, particularly with rapid dose escalation. The FDA explicitly warns that these reactions can occur even after brief treatment interruptions, making your patient's restart particularly high-risk 1.

Monitoring Requirements:

• Blood pressure: Check lying and standing BP at each dose increase (>20 mmHg systolic or >10 mmHg diastolic drop indicates orthostatic hypotension) 2
• Heart rate: Monitor routinely as 68% develop tachycardia 2
• CRP levels: Measure at baseline and weekly for at least 4 weeks to detect inflammation from too-rapid titration 3, 4
• Clozapine levels: Once at steady state (typically after 5-7 days at stable dose), target 350-600 ng/mL therapeutic range 3

Dosing Strategy Modifications

Use divided dosing (twice daily) rather than once-daily dosing to minimize cardiovascular and sedation risks 1. The FDA specifically recommends divided dosing to reduce orthostatic hypotension, bradycardia, and syncope risk.

Slower Titration May Be Needed If:

• Patient develops tachycardia (>100 bpm at rest)
• Orthostatic hypotension occurs
• CRP elevates during titration (suggests inflammation from too-rapid titration) 3, 4
• Patient is obese or on valproate (both reduce clozapine metabolism) 3
• Patient is female non-smoker (lower CYP1A2 activity requires lower doses) 3

Subsequent Dose Increases

After reaching the initial target of 300-450 mg/day:

• Further increases: 100 mg or less, once or twice weekly 1
• Maximum dose: 900 mg daily 1
• Therapeutic monitoring: Essential to guide dosing beyond initial target, aiming for levels >350 ng/mL before declaring non-response 5

Common Pitfalls to Avoid

1. Too-rapid titration: This is the primary cause of early myocarditis, orthostatic hypotension, and syncope 1, 3
2. Once-daily dosing during titration: Increases cardiovascular risk 1
3. Ignoring CRP elevations: Rising CRP during titration indicates either clozapine-induced inflammation or concurrent infection requiring dose adjustment or pause 3, 4
4. Missing the 48-hour rule: If patient misses >48 hours of doses, re-titration from 12.5 mg is required due to loss of tolerance 6

Special Circumstances

If your patient develops fever, chest pain, tachycardia, or flu-like symptoms during titration, immediately check troponin, CRP, and ECG to rule out myocarditis 1. Myocarditis typically occurs in the first months and can be fatal if clozapine is continued 1.

The evidence strongly supports that slow, divided-dose titration with close cardiovascular and inflammatory monitoring prevents the majority of serious early adverse events that lead to clozapine discontinuation 1, 3.